AIF3 / AIFM3 antibody

Principal name

AIF3 / AIFM3 antibody

Alternative names for AIF3 / AIFM3 antibody

Apoptosis-inducing factor 3, AIFL

SwissProt ID

Q3TY86 (Mouse), Q96NN9 (Human)

Gene ID

150209 (AIFM3), 72168 (Aifm3)

Available reactivities

Hu (Human), Ms (Mouse), Rt (Rat), Bov (Bovine), Chk (Chicken), Can (Canine), GP (Guinea Pig), Por (Porcine), Rb (Rabbit), Ze (Zebrafish)

Available hosts

Rabbit

Available applications

Paraffin Sections (P), Western blot / Immunoblot (WB), Enzyme Immunoassay (E), Immunocytochemistry/Immunofluorescence (ICC/IF)

Background of AIF3 / AIFM3 antibody

Kit Component:
- KN301040G1, Aifm3 gRNA vector 1 in pCas-Guide vector
- KN301040G2, Aifm3 gRNA vector 2 in pCas-Guide vector
- KN301040D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector
CRISPR Manual:
CRISPR/CAS9 Genome Editing Manual

General readings

Urbano,A., (2005) EMBO J. 24 (15), 2815-2826

Items 21 to 22 of 22 total

per page
Page:
  1. 1
  2. 2

Human Lenti ORF Particles

Catalog No.    

Lenti ORF particles, AIFM3 (Myc-DDK tagged) - Human apoptosis-inducing factor, mitochondrion-associated, 3 (AIFM3), nuclear gene encoding mitochondrial protein, transcript variant 2 , 200 uL, >10^7 TU/mL

Lenti ORF particles, AIFM3 (Myc-DDK tagged) - Human apoptosis-inducing factor, mitochondrion-associated, 3 (AIFM3), nuclear gene encoding mitochondrial protein, transcript variant 2 , 200 uL, >10^7 TU/mL  
200 µl / €969.00
  OriGene Technologies, Inc.

Lenti ORF particles, AIFM3 (Myc-DDK-tagged)-Human apoptosis-inducing factor, mitochondrion-associated, 3 (AIFM3), nuclear gene encoding mitochondrial protein, transcript variant 3, 200 uL, >10^7 TU/mL

Lenti ORF particles, AIFM3 (Myc-DDK-tagged)-Human apoptosis-inducing factor, mitochondrion-associated, 3 (AIFM3), nuclear gene encoding mitochondrial protein, transcript variant 3, 200 uL, >10^7 TU/mL  
200 µl / €1,164.00
  OriGene Technologies, Inc.

Items 21 to 22 of 22 total

per page
Page:
  1. 1
  2. 2
  • LinkedIn